✦ LIBER ✦

Therapy for hepatic fibrosis: Revisiting the preclinical models

✍ Scribed by D. Montgomery Bissell

Book ID: 119218386
Publisher: Elsevier
Year: 2011
Tongue: French
Weight: 191 KB
Volume: 35
Category: Article
ISSN: 2210-7401
DOI: 10.1016/j.clinre.2011.03.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Curcumin: potential for hepatic fibrosis

Curcumin: potential for hepatic fibrosis therapy?

✍ M A O'Connell; S A Rushworth 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB

Angiogenic cell therapy for hepatic fibr

Angiogenic cell therapy for hepatic fibrosis

✍ Takato Ueno; Toru Nakamura; Takuji Torimura; Michio Sata 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 370 KB

Targeted mouse models for preclinical th

Targeted mouse models for preclinical therapy trials

✍ Siveke, Jens T. 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 42 KB

Revisiting ovarian cancer preclinical mo

Revisiting ovarian cancer preclinical models: Implications for a better management of the disease

✍ Ricci, Francesca; Broggini, Massimo; Damia, Giovanna 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 294 KB

A Novel Plasma Filtration Therapy for He

A Novel Plasma Filtration Therapy for Hepatic Failure: Preclinical Studies

✍ Jacek Rozga; Yutaka Umehara; Andrey Trofimenko; Tomohito Sadahiro; Achilles A De 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Gene therapy for hepatic fibrosis—bringi

Gene therapy for hepatic fibrosis—bringing treatment into the new millennium

✍ Don C. Rockey 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB

We eliminated type beta transforming growth factor (TGF-beta) signaling by adenovirus-mediated local expression of a dominant-negative type II TGF-beta receptor (AdCATbeta-TR) in the liver of rats treated with dimethylnitrosamine, a model of persistent liver fibrosis. In rats that received a single